In vitro generated moLCs for testing Langerin-ligand coated nanoparticles for vaccination

被引:0
|
作者
Bellmann, L. [1 ]
Zelle-Rieser, C. [1 ]
Tripp, C. H. [1 ]
Milne, P. [2 ]
Wilflingseder, D. [3 ]
Zaderer, V. [3 ]
Schulze, J. [4 ]
Rentzsch, M. [4 ]
Collin, M. [2 ]
Rademacher, C. [4 ]
Romani, N. [1 ]
Stoitzner, P. [1 ]
机构
[1] Med Univ Innsbruck, Dept Dermatol Venereol & Allergol, Innsbruck, Austria
[2] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England
[3] Med Univ Innsbruck, Div Hyg & Med Microbiol, Innsbruck, Austria
[4] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Potsdam, Germany
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P 09
引用
收藏
页码:20 / 20
页数:1
相关论文
共 2 条
  • [1] Ligand Size and Conformation Affect the Behavior of Nanoparticles Coated with in Vitro and in Vivo Protein Corona
    Zhang, Huajin
    Wu, Tianmu
    Yu, Wenqi
    Ruan, Shaobo
    He, Qin
    Gao, Huile
    ACS APPLIED MATERIALS & INTERFACES, 2018, 10 (10) : 9094 - 9103
  • [2] Selective killing of breast cancer cells expressing activated CD44 using CD44 ligand-coated nanoparticles in vitro and in vivo
    Yang, Cuixia
    He, Yiqing
    Zhang, Huizhen
    Liu, Yiwen
    Wang, Wenjuan
    Du, Yan
    Gao, Feng
    ONCOTARGET, 2015, 6 (17) : 15283 - 15296